Full Answer
Stenotrophomonas maltophilia has had multiple different names in the past. It was first found in a pleural effusion in 1943 and given the name Bacterium bookeri. It was then renamed to Pseudomonas maltophilia in 1961.
A specific peptide inhibitor of the class B metallo-β-lactamase L-1 from Stenotrophomonas maltophilia identified using phage display. J. Antimicrob. Chemother.55:252–255 [PubMed] [Google Scholar] 306. Savini V, et al. 2010. Chloramphenicol and rifampin may be the only options against Stenotrophomonas maltophilia.
Alonso A, Sanchez P, Martínez JL. Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistance. Antimicrob Agents Chemother.
Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates. Antimicrob. Agents Chemother.48:666–669 [PMC free article][PubMed] [Google Scholar] 28. Bathe S, Lebuhn M, Ellwart JW, Wuertz S, Hausner M. 2004.
B96. 89 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM B96. 89 became effective on October 1, 2021.
R78. 81 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
ICD-10 code: U81. 25 Multidrug-resistant Citrobacter freundii complex 3MRGN.
9: Fever, unspecified.
BacteremiaICD-10 code R78. 81 for Bacteremia is a medical classification as listed by WHO under the range - Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified .
ICD-10 code: A49. 9 Bacterial infection, unspecified.
Enterobacter species are members of the ESKAPE group (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter species), which are described as the leading cause of resistant nosocomial infections (7, 10, 11, 13,–20).
ICD-10 code A41. 81 for Sepsis due to Enterococcus is a medical classification as listed by WHO under the range - Certain infectious and parasitic diseases .
87086 Culture, bacterial; quantitative, colony count, urine.
ICD-10-CM Code for Cough R05.
Codes in the ICD-10-CM code set can have anywhere from three to seven characters. The more characters there are, the more specific the diagnosis. The first character is always alpha (i.e., a letter), but characters two through seven can be either alpha or numeric.
Acute febrile illness was defined as a patient with fever of 38°C or higher at presentation to ED or history of fever that persisted for 2–7 days with no localizing source.
Stenotrophomonas maltophilia has had multiple different names in the past. It was first found in a pleural effusion in 1943 and given the name Bacterium bookeri. It was then renamed to Pseudomonas maltophilia in 1961. It was moved to the genus Xanthomonas in 1983, and most recently to Stenotrophomonas in 1993.
S. maltophilia frequently colonizes humid surfaces such as the tubes used in mechanical ventilation and indwelling urinary catheters as well as medical devices such as suction catheters and endoscopes. Infection is usually facilitated by the presence of prosthetic material (plastic or metal), and the most effective treatment is ...
The growth of S. maltophilia in microbiological cultures of respiratory or urinary specimens is difficult to interpret due to its low pathogenicity, and not a proof of infection.
Deliberate induction of inflammatory responses is the main pathogenic mechanisms of S. maltophilia infection. S. maltophilia secretes outer membrane vesicles (OMVs), that cause an inflammatory response. OMVs from S. maltophilia ATCC 13637 were found to be cytotoxic to human lung epithelial cells.
S. maltophilia is naturally resistant to many broad-spectrum antibiotics (including all carbapenems) due to the production of two inducible chromosomal metallo-β-lactamases (designated L1 and L2). This makes treatment of infected patients very difficult.
In immunocompetent individuals, S. maltophilia is a relatively unusual cause of pneumonia, urinary tract infection, or bloodstream infection; in immunocompromised patients, however, S. maltophilia is a growing source of latent pulmonary infections. S. maltophilia colonization rates in individuals with cystic fibrosis have been increasing.
In immunocompromised patients, S. maltophilia can lead to nosocomial infections. It is also an emerging nosocomial pathogen associated with opportunistic infections in patients with cystic fibrosis, cancer, and HIV. Adherence of this organism to abiotic surfaces such as medical implants and catheters represents a major risk for hospitalized ...